Latest spending stopgap extends limit on DOJ funding for medical marijuana prosecutions though March 23, 2018

As reported here under the headline “Federal medical cannabis protection extended again,” the stop-gap federal funding approach to stopping possible federal prosecution of state-compliant medical marijuana providers:

The only federal law formally preventing the U.S. Department of Justice from prosecuting medical marijuana businesses has once more been given a new lease on life.  This time, the Rohrabacher-Blumenauer Amendment – formerly known as Rohrabacher-Farr – has been extended until March 23 under the budget deal passed by Congress and signed Friday morning by President Donald Trump….

Rohrabacher-Blumenauer prohibits the DOJ from using federal funds to interfere with state-legal MMJ laws and companies.  The measure does not protect recreational marijuana businesses….

It’s possible the amendment will be included in a larger spending package that is expected to be approved by March 23.  But there’s no guarantee at this point, given a change in procedural rules in the House of Representatives last year that has prevented amendments like Rohrabacher-Blumenauer from being added to the budget.